Citations

Clear

4201 citation(s) found for "Chen, Chen".

MicroRNA-513 Regulates B7-H1 Translation and Is Involved in IFN-γ-Induced B7-H1 Expression in Cholangiocytes
Gong, Ai‐Yu, Zhou, Rui , Hu, Guoku , Splinter, Patrick L., O’Hara, Steven P. , Soukup, Garrett A. , Li, Xiaoqing , LaRusso, Nicholas F. , Dong, Haidong , Chen, Xian‐Ming

Mayo Clinic

The Journal of Immunology | April 18, 2014 | Volume: 182 | Issue: 3 | Pages: 1325-1333

10.4049/jimmunol.182.3.1325 | PMID 19155478 Get It

Abstract Biliary epithelial cells (cholangiocytes) respond to proinflammatory cytokines such as IFN-γ and actively participate in the regulation of biliary inflammatory response in the liver. B7-H1 (also known as CD274 or PD-L1) is a member of the B7 costimulatory molecules and plays a critical immunoregulatory role in cell-mediated immune responses. In this study, we show that resting human cholangiocytes in culture express B7-H1 mRNA, but not B7-H1 protein. IFN-γ induces B7-H1 protein expression and alters the microRNA (miRNA) expression profile in cholangiocytes. Of those IFN-γ-down-regulated miRNAs, we identified microRNA-513 (miR-513) with complementarity to the 3′-untranslated region of B7-H1 mRNA. Targeting of the B7-H1 3′-untranslated region by miR-513 results in translational repression. Transfection of cholangiocytes with an antisense oligonucleotide to miR-513 induces B7-H1 protein expression. Additionally, transfection of miR-513 precursor decreases IFN-γ-induced B7-H1 protein expression and consequently influences B7-H1-associated apoptotic cell death in cocultured Jurkat cells. Thus, miR-513 regulates B7-H1 translation and is involved in IFN-γ-induced B7-H1 expression in human cholangiocytes, suggesting a role for miRNA-mediated gene silencing in the regulation of cholangiocyte response to IFN-γ.
Dopamine vs Nesiritide for Acute Heart Failure With Renal Dysfunction—Reply
Chen, Horng H. , Redfield, Margaret M.

Mayo Clinic

JAMA | April 15, 2014 | Volume: 311 | Issue: 15 | Pages: 1565

10.1001/jama.2014.2462 | PMID 24737372 Get It

Tumor Hypomethylation at 6p21.3 Associates with Longer Time to Recurrence of High-Grade Serous Epithelial Ovarian Cancer
Wang, Chen , Cicek, Mine , Charbonneau, Bridget, Kalli, Kimberly R., Armasu, Sebastian M. , Konecny, Gottfried E. , Winterhoff, Boris , Fan, Jian-Bing, Bibikova, Marina, Chien, Jeremy , Shridhar, Viji , Block, Matthew S. , Hartmann, Lynn C. , Visscher, Daniel W., Cunningham, Julie M. , Knutson, Keith L. , Goode, Ellen L. , Cicek, Mine S., Larson, Melissa C. , Knutson, Keith L. , Fridley, Brooke L. , Chien, Jeremey , Wang, Chen

Mayo Clinic

Cancer Research | April 12, 2014 | Volume: 74 | Issue: 11 | Pages: 3084-3091

10.1158/0008-5472.can-13-3198 | PMID 24728075 Get It

Abstract To reveal biologic mechanisms underlying clinical outcome of high-grade serous (HGS) epithelial ovarian carcinomas (EOC), we evaluated the association between tumor epigenetic changes and time to recurrence (TTR). We assessed methylation at approximately 450,000 genome-wide CpGs in tumors of 337 Mayo Clinic (Rochester, MN) patients. Semi-supervised clustering of discovery (n = 168) and validation (n = 169) sets was used to determine clinically relevant methylation classes. Clustering identified two methylation classes based on 60 informative CpGs, which differed in TTR in the validation set [R vs. L class, P = 2.9 × 10−3, HR = 0.52; 95% confidence interval (CI), 0.34–0.80]. Follow-up analyses considered genome-wide tumor mRNA expression (n = 104) and CD8 T-cell infiltration (n = 89) in patient subsets. Hypomethylation of CpGs located in 6p21.3 in the R class associated with cis upregulation of genes enriched in immune response processes (TAP1, PSMB8, PSMB9, HLA-DQB1, HLA-DQB2, HLA-DMA, and HLA-DOA), increased CD8 T-cell tumor infiltration (P = 7.6 × 10−5), and trans-regulation of genes in immune-related pathways (P = 1.6 × 10−32). This is the most comprehensive assessment of clinical outcomes with regard to epithelial ovarian carcinoma tumor methylation to date. Collectively, these results suggest that an epigenetically mediated immune response is a predictor of recurrence and, possibly, treatment response for HGS EOC. Cancer Res; 74(11); 3084–91. ©2014 AACR.
Inflammation-Induced NFATc1–STAT3 Transcription Complex Promotes Pancreatic Cancer Initiation by Kras G12D
Baumgart, Sandra, Chen, Nai-Ming, König, Alexander , Zhang, Jin‐San , Singh, Shiv K. , Wolf, Elmar , Bartkuhn, Marek , Esposito, Iréne , Heßmann, Elisabeth , Reinecke, Johanna, Nikorowitsch, Julius, Brunner, Marius , Fernández-Zapico, Martín E. , Smyrk, Thomas C. , Bamlet, William R. , Neeße, Albrecht , Gress, Thomas M. , Billadeau, Daniel D. , Ellenrieder, Volker , Siveke, Jens T. , Singh, Garima, Smyrk, Thomas, Eilers, Martin, Neesse, Albrecht, Tuveson, David, Urrutia, Raúl , Siveke, Jens , Singh, Garima Prateek , Eilers, Martin , Tuveson, David A. , Bamlet, William R , Singh, Shiv K

Mayo Clinic

Cancer Discovery | April 3, 2014 | Volume: 4 | Issue: 6 | Pages: 688-701

10.1158/2159-8290.cd-13-0593 | PMID 24694735 Get It

Abstract Cancer-associated inflammation is a molecular key feature in pancreatic ductal adenocarcinoma. Oncogenic KRAS in conjunction with persistent inflammation is known to accelerate carcinogenesis, although the underlying mechanisms remain poorly understood. Here, we outline a novel pathway whereby the transcription factors NFATc1 and STAT3 cooperate in pancreatic epithelial cells to promote KrasG12D-driven carcinogenesis. NFATc1 activation is induced by inflammation and itself accelerates inflammation-induced carcinogenesis in KrasG12D mice, whereas genetic or pharmacologic ablation of NFATc1 attenuates this effect. Mechanistically, NFATc1 complexes with STAT3 for enhancer–promoter communications at jointly regulated genes involved in oncogenesis, for example, Cyclin, EGFR and WNT family members. The NFATc1–STAT3 cooperativity is operative in pancreatitis-mediated carcinogenesis as well as in established human pancreatic cancer. Together, these studies unravel new mechanisms of inflammatory-driven pancreatic carcinogenesis and suggest beneficial effects of chemopreventive strategies using drugs that are currently available for targeting these factors in clinical trials. Significance: Our study points to the existence of an oncogenic NFATc1–STAT3 cooperativity that mechanistically links inflammation with pancreatic cancer initiation and progression. Because NFATc1–STAT3 nucleoprotein complexes control the expression of gene networks at the intersection of inflammation and cancer, our study has significant relevance for potentially managing pancreatic cancer and other inflammatory-driven malignancies. Cancer Discov; 4(6); 688–701. ©2014 AACR. This article is highlighted in the In This Issue feature, p. 621
P4‐284: Independent and epistatic effects of Val66Met BDNF and ApoE polymorphisms on BETA‐AMYLOID deposition in cognitively normal individuals using PiB‐PET imaging
Huentelman, Matthew J. , Corneveaux, Jason J., Roontiva, Auttawut, Caselli, Richard J. , Fleisher, Adam , Bai, Lu , Reiman, Eric M. , During, Emmanuel , Elahi, Fanny M. , Chen, Kewei , Thiyyagura, Pradeep , Liu, Xiaofen

Mayo Clinic

Alzheimer's & Dementia | March 29, 2014 | Volume: 8 | Issue: 4S_Part_21 | Pages: No page available

10.1016/j.jalz.2013.08.065 Get It

Five National Cancer Institute–designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials
Hawk, Ernest T. , Habermann, Elizabeth B. , Ford, Jean G. , Wenzel, Jennifer , Brahmer, Julie R. , Jones, Lovell A. , Hurd, Thelma C. , Nguyen, Lynne, Ahluwalia, Jasjit S. , Vickers, Selwyn M. , Chen, Moon S. , Rogers, Lisa M. , Fouad, Mona N. , Habermann, Elizabeth

Mayo Clinic

Cancer | March 18, 2014 | Volume: 120 | Issue: S7 | Pages: 1113-1121

10.1002/cncr.28571 | PMID 24643649 Get It

BACKGROUNDTo ensure that National Institutes of Health‐funded research is relevant to the population's needs, specific emphasis on proportional representation of minority/sex groups into National Cancer Institute (NCI) cancer centers' clinical research programs is reported to the NCI.METHODSEMPaCT investigators at 5 regionally diverse comprehensive cancer centers compared data reported to the NCI for their most recent Cancer Center Support Grant competitive renewal to assess and compare the centers' catchment area designations, data definitions, data elements, collection processes, reporting, and performance regarding proportional representation of race/ethnicity and sex subsets.RESULTSCancer centers' catchment area definitions differed widely in terms of their cancer patient versus general population specificity, levels of specificity, and geographic coverage. Racial/ethnic categories were similar, yet were defined differently, across institutions. Patients' socioeconomic status and insurance status were inconsistently captured across the 5 centers.CONCLUSIONSCatchment area definitions and the collection of patient‐level demographic factors varied widely across the 5 comprehensive cancer centers. This challenged the assessment of success by cancer centers in accruing representative populations into the cancer research enterprise. Accrual of minorities was less than desired for at least 1 racial/ethnic subcategory at 4 of the 5 centers. Institutions should clearly and consistently declare their primary catchment area and the rationale and should report how race/ethnicity and sex are defined, determined, collected, and reported. More standardized, frequent, consistent collection, reporting, and review of these data are recommended, as is a commitment to collecting socioeconomic data, given that socioeconomic status is a primary driver of cancer disparities in the United States. Cancer 2014;120(7 suppl):1113–21. © 2014 American Cancer Society.
Long‐term follow‐up of a phase 2 trial of single agent lenalidomide in previously untreated patients with chronic lymphocytic leukaemia
Chen, Christine I. , Paul, Harminder, Wang, Trina, Le, Lisa W. , Dave, Nimisha, Kukreti, Vishal , Wei, Ellen, Lau, Anthea , Bergsagel, P. Leif , Trudel, Suzanne , Bergsagel, P. Leif

Mayo Clinic

British Journal of Haematology | February 24, 2014 | Volume: 165 | Issue: 5 | Pages: 731-733

10.1111/bjh.12785 | PMID 24611934 Get It

A leukemic presentation of a “triple-hit” lymphoma
Ketterling, Rhett P. , Chen, Dong , Ketterling, Rhett P

Mayo Clinic

Blood | February 20, 2014 | Volume: 123 | Issue: 8 | Pages: 1126-1126

10.1182/blood-2013-11-540658 | PMID 24701632 Get It

Microtubule-Mediated Defects in Junctophilin-2 Trafficking Contribute to Myocyte Transverse-Tubule Remodeling and Ca 2+ Handling Dysfunction in Heart Failure
Zhang, Caimei , Chen, Biyi, Guo, Ang , Zhu, Yanqi, Miller, Jordan D. , Gao, Shan , Yuan, Can , Kutschke, William , Weiss, Robert M. , Wehrens, Xander H.T. , Jiang, Hong , Johnson, Frances L. , Santana, Luis F. , Anderson, Mark E. , Song, Long‐Sheng , Zimmerman, Kathy , Wehrens, Xander H T , Miller, Jordan

Mayo Clinic

Circulation | February 12, 2014 | Volume: 129 | Issue: 17 | Pages: 1742-1750

10.1161/circulationaha.113.008452 | PMID 24519927 Get It

Background— Cardiac dysfunction in failing hearts of human patients and animal models is associated with both microtubule densification and transverse-tubule (T-tubule) remodeling. Our objective was to investigate whether microtubule densification contributes to T-tubule remodeling and excitation–contraction coupling dysfunction in heart disease. Methods and Results— In a mouse model of pressure overload–induced cardiomyopathy by transaortic banding, colchicine, a microtubule depolymerizer, significantly ameliorated T-tubule remodeling and cardiac dysfunction. In cultured cardiomyocytes, microtubule depolymerization with nocodazole or colchicine profoundly attenuated T-tubule impairment, whereas microtubule polymerization/stabilization with taxol accelerated T-tubule remodeling. In situ immunofluorescence of heart tissue sections demonstrated significant disorganization of junctophilin-2 (JP2), a protein that bridges the T-tubule and sarcoplasmic reticulum membranes, in transaortic banded hearts as well as in human failing hearts, whereas colchicine injection significantly preserved the distribution of JP2 in transaortic banded hearts. In isolated mouse cardiomyocytes, prolonged culture or treatment with taxol resulted in pronounced redistribution of JP2 from T-tubules to the peripheral plasma membrane, without changing total JP2 expression. Nocodazole treatment antagonized JP2 redistribution. Moreover, overexpression of a dominant-negative mutant of kinesin 1, a microtubule motor protein responsible for anterograde trafficking of proteins, protected against JP2 redistribution and T-tubule remodeling in culture. Finally, nocodazole treatment improved Ca 2+ handling in cultured myocytes by increasing the amplitude of Ca 2+ transients and reducing the frequency of Ca 2+ sparks. Conclusion— Our data identify a mechanistic link between microtubule densification and T-tubule remodeling and reveal microtubule-mediated JP2 redistribution as a novel mechanism for T-tubule disruption, loss of excitation–contraction coupling, and heart failure.